Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 117 entries
View as:

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04718896 Org: User:
Start: 04/06/21 End: 03/12/25 Due: 03/12/26

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03010527 Org: User:
Start: 12/14/16 End: 09/25/18 Due: 09/25/19

A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06533475 Org: User:
Start: 09/06/24 End: 11/17/24 Due: 11/17/25

A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04643483 Org: User:
Start: 06/30/21 End: 04/30/26 Due: 04/30/27

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06471361 Org: User:
Start: 08/27/24 End: 02/03/25 Due: 02/03/26

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03370120 Org: User:
Start: 08/27/18 End: 12/11/20 Due: 12/11/21

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03536884 Org: User:
Start: 06/13/18 End: 08/09/23 Due: 08/09/24

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04643457 Org: User:
Start: 11/27/20 End: 06/06/24 Due: 06/06/25

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03230292 Org: User:
Start: 07/03/17 End: 03/06/19 Due: 03/06/20

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04053881 Org: User:
Start: 08/21/19 End: 12/02/22 Due: 12/02/23

A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03025542 Org: User:
Start: 12/27/16 End: 12/11/17 Due: 12/11/18

CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT03559660 Org: User:
Start: - End: - Due: -

An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT02625090 Org: User:
Start: 12/03/15 End: 11/24/20 Due: 11/24/21

A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)

Phase: N/A Priority: Normal
NCT ID: NCT04185415 Org: User:
Start: 12/03/19 End: 11/17/21 Due: 11/17/22

A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women

Phase: N/A Priority: Normal
NCT ID: NCT06961747 Org: User:
Start: 05/12/25 End: 05/25/26 Due: 05/25/27

A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04867642 Org: User:
Start: 04/29/21 End: 02/27/23 Due: 02/27/24

A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT04857307 Org: User:
Start: 04/28/21 End: 04/05/22 Due: 04/05/23

A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women

Phase: N/A Priority: Normal
NCT ID: NCT06720714 Org: User:
Start: 12/03/24 End: 05/12/25 Due: 05/12/26

An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06435312 Org: User:
Start: 11/19/24 End: 12/07/27 Due: 12/07/28

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03992196 Org: User:
Start: 12/03/19 End: 09/01/22 Due: 09/01/23

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT06921850 Org: User:
Start: 04/07/25 End: 05/30/29 Due: 05/30/30

A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06555601 Org: User:
Start: 07/31/24 End: 01/08/26 Due: 01/08/27

A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT05109234 Org: User:
Start: 03/30/22 End: 03/18/25 Due: 03/18/26

A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04109976 Org: User:
Start: 08/13/19 End: 11/13/20 Due: 11/13/21

A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT04131517 Org: User:
Start: 10/23/19 End: 05/22/20 Due: 05/22/21